Aspen Pharmacare

Aspen Pharmacare

APN.JO
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

APN.JO · Stock Price

ZAR 147.83+22.98 (+18.41%)
Market Cap: $4.0B

Historical price data

Market Cap: $4.0BFounded: 1988Employees: 9,500+HQ: Johannesburg, South Africa

Overview

Aspen Pharmacare's mission is to improve patient health globally through high-quality, affordable medicines. The company has achieved its position as a multinational leader through a disciplined strategy of strategic acquisitions, geographic expansion into over 115 countries, and vertical integration across manufacturing and commercial operations. Its core strategy focuses on marketing and manufacturing a broad portfolio of post-patent, branded pharmaceuticals and sterile injectables, leveraging a world-class, regulatory-approved manufacturing footprint to serve both developed and emerging markets.

AnaestheticsThrombosisOncology (Cytotoxic)Consumer HealthVarious (CNS, Cardiovascular, Respiratory)

Technology Platform

Aspen's core platform is advanced, globally compliant pharmaceutical manufacturing technology, specializing in complex sterile injectables (cytotoxics, biologics), active pharmaceutical ingredient (API) synthesis, and a digitally-enabled, resilient global supply chain.

Funding History

1
IPOUndisclosed